R&D difficulties and optimization strategies of GLP-1 RAs The short half-life of natural GLP-1 poses a challenge for drug development
Constipation, nausea, vomiting, diarrhea, and stomach pain are the most common side effects
The World Anti-Doping Agency (WADA) bans IGF-1 variants in competitive sports
Lipo-C is a compounded injectable formulation of lipotropic agents, amino acids, and vitamins, typically delivered as part of a medical weight loss program
Lifevantage Protandim NRF1
AA received research grants and lecture or advisory board fees from MSD, AstraZeneca, Novartis, Boehringer Ingelheim, Sanofi, Mediolanum, Janssen, Novo Nordisk, Lilly, Servier and Takeda